Second degree AV block: Difference between revisions
No edit summary |
|||
(6 intermediate revisions by 5 users not shown) | |||
Line 6: | Line 6: | ||
}} | }} | ||
{{Second degree AV block}} | {{Second degree AV block}} | ||
{{CMG}}; {{AE}} {{CZ}} | |||
'''For patient information, click [[Second degree AV block (patient information)|here]]''' | |||
{{CMG}}; {{AE}} {{Sara.Zand}} [[User:Mohammed Salih|Mohammed Salih, M.D.]] {{sali}} {{AEL}} {{CZ}} | |||
{{SK}} Mobitz type I AV block, Mobitz type II AV block, advanced second degree AV block, Wenckebach AV block, Wenckebach phenomenon | |||
==[[Second degree AV block overview|Overview]]== | ==[[Second degree AV block overview|Overview]]== | ||
Line 55: | Line 60: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Arrhythmia]] |
Latest revision as of 15:21, 12 July 2021
Second degree AV block | |
Second degree AV block. Mobitz Type II |
Second degree AV block Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Second degree AV block On the Web |
American Roentgen Ray Society Images of Second degree AV block |
Risk calculators and risk factors for Second degree AV block |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Mohammed Salih, M.D. Syed Musadiq Ali M.B.B.S.[3] Ahmed Elsaiey, MBBCH [4] Cafer Zorkun, M.D., Ph.D. [5]
Synonyms and keywords: Mobitz type I AV block, Mobitz type II AV block, advanced second degree AV block, Wenckebach AV block, Wenckebach phenomenon
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Second degree AV block from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | EKG Examples | Chest X Ray | Echocardiography | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies